Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Or EisenbergCFO | NeuroSense TherapeuticsNRSN | Open-market buy | 06/16 | 06/17 | 250,000 sh | $0.80 | $200,000 | +19.9% |
NeuroSense TherapeuticsNRSN | Open-market buy | 06/16 | 06/17 | 250,000 sh | $0.80 | $200,000 | +5.8% |